All cardiac care professionals could see more professional development, opportunity.
With the switch to value-based medicine, more nurses are becoming hospital CEOs reads an article published online today in Hospitals & Health Networks Magazine.
Three hospitals in the six-hospital Memorial Healthcare System in Florida are now run by nurses—for RNs, it seems, the career ladder has grown longer, with more nurses climbing higher in healthcare management.
Beyond Florida, an August 2016 article in Becker’s Hospital Review listed 33 nurses who transitioned to hospital CEOs.
Why are more hospitals tapping nurses to run the organization? Management competencies are changing, says Lamont Yoder, RN, of the American Organization of Nurse Executives to H&HN Magazine’s Maggie Van Dyke.
Continue reading Career ladders getting higher for nurses—what about allied health?
Plus, get ready for high sensitivity cardiac Troponin assays in practice.
Laboratory medicine experts discovered a new lipid biomarker panel to detect heart failure with reduced ejection fraction (HFrEF) even before symptoms present, with “much greater certainty than standard tests for this condition,” according to a January 5 press release from the American Association for Clinical Chemistry (AACC).
The January issue of the AACC’s journal, Clinical Chemistry focuses on cardiovascular disease and features research reflecting a “growing understanding of the molecular signatures of heart disease,” according to the press release, and a trend towards developing “more precise tests for the early diagnosis, monitoring, and targeted treatment.”
The study in question identified three new cardiac lipid biomarkers, a cardiac lipid panel (CLP), which “significantly improved diagnostic performance” when combined with the current standard biomarker approach for diagnosing heart failure, NT-proBNP.
Continue reading AACC scientists identify new cardiac biomarker
A new joint report released today by the American College of Cardiology (ACC) and the American Heart Association (AHA) offers practitioners and stakeholders ten evidence-based quality and performance measures to prevent sudden cardiac death (SCD).
“This is the first comprehensive measure set in the area of SCD prevention,” says Sana Al-Khatib, MD, co-chair of the report writing committee in an ACC press release. “Our vision is that these measures will be developed, tested and implemented in clinical practice and that implementation will improve patient care and outcomes.”
Sudden cardiac death a “healthcare crisis”
The American Heart Association reports more than 350,000 out-of-hospital cardiac arrests (OHCA) occurring in 2016 with only 12 percent of people surviving to hospital discharge. These approximate statistics suggest more than 308,000 sudden cardiac deaths per year.
Continue reading ACC and AHA Release 10 “Comprehensive” Measures to Combat Sudden Cardiac Death
Additional cardiac imaging often unnecessary
Last week, Mayo Clinic researchers showed that using a shared decision-making aid to involve more patients in care decisions can prevent both unnecessary hospitalization and more advanced cardiac tests for patients with low-risk chest pain.
The “Chest Pain Choice” shared decision-making aid is one of the latest evidence-based practices built on high-sensitivity troponin rule-out of acute coronary syndrome for ED patients reporting acute chest pain. After the one-hour test, an additional “one minute” discussion to educate patients about their risk and reach a shared decision can prevent further unnecessary and costly testing.
ACVP Blog has discussed decision-making for acute chest pain before, suggesting that the fact the cardiac biomarker test can safely and accurately rule-out acute coronary syndrome within one hour “challenges [the] need” for commonly-used noninvasive imaging prior to patient discharge.
Continue reading One Minute, Shared Decision-Making Aid Reduces Unnecessary Hospitalization